Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
1995-11-20
pubmed:abstractText
To compare the clinical efficacy, effect on serum C-reactive protein (CRP), serum amyloid A (SAA), and plasma interleukin-6 (IL-6) levels, and safety of tenidap with a combination of hydroxychloroquine-plus-piroxicam, and piroxicam alone, in the treatment of rheumatoid arthritis (RA) patients.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0004-3591
pubmed:author
pubmed:issnType
Print
pubmed:volume
38
pubmed:owner
NLM
pubmed:authorsComplete
N
pubmed:pagination
1447-56
pubmed:dateRevised
2010-3-24
pubmed:meshHeading
pubmed-meshheading:7575694-Adult, pubmed-meshheading:7575694-Aged, pubmed-meshheading:7575694-Aged, 80 and over, pubmed-meshheading:7575694-Alanine Transaminase, pubmed-meshheading:7575694-Anti-Inflammatory Agents, Non-Steroidal, pubmed-meshheading:7575694-Antirheumatic Agents, pubmed-meshheading:7575694-Arthritis, Rheumatoid, pubmed-meshheading:7575694-C-Reactive Protein, pubmed-meshheading:7575694-Double-Blind Method, pubmed-meshheading:7575694-Drug Therapy, Combination, pubmed-meshheading:7575694-Female, pubmed-meshheading:7575694-Humans, pubmed-meshheading:7575694-Hydroxychloroquine, pubmed-meshheading:7575694-Indoles, pubmed-meshheading:7575694-Interleukin-6, pubmed-meshheading:7575694-Male, pubmed-meshheading:7575694-Middle Aged, pubmed-meshheading:7575694-Piroxicam, pubmed-meshheading:7575694-Proteinuria, pubmed-meshheading:7575694-Time Factors, pubmed-meshheading:7575694-Treatment Outcome
pubmed:year
1995
pubmed:articleTitle
Tenidap in rheumatoid arthritis. A 24-week double-blind comparison with hydroxychloroquine-plus-piroxicam, and piroxicam alone.
pubmed:affiliation
Birmingham VA Hospital, AL 35233, USA.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study